Capital Markets Day and demerger archive
GSK plc demerged it’s world leading consumer healthcare business, Haleon, on 18 July 2022.
The Capital Markets Day was hosted virtually on 28 February 2022.
Read the Prospectus in relation to the admission of the Haleon plc ordinary shares along with associated documents via the links below:
Consumer Healthcare Capital Markets Day
Haleon CEO, Brian McNamara, and other members of the Executive Leadership team hosted a virtual Capital Markets Day on 28 February 2022. The programme outlined the strategy for Haleon to deliver sustainable, above-market growth and strong value creation.
Scroll down access the presentations, transcripts, press release and other supplementary information.
Watch the event
Transcripts and additional downloads
Introduction Sonya Ghobrial, Head of Investor Relations
Delivering shareholder value Emma Walmsley, Chief Executive Officer, GSK
Haleon: A global consumer healthcare leader delivering sustainable above market growth and attractive returns Brian McNamara, Chief Executive Officer
Competitive capabilities to outperform in the market Tamara Rogers, Chief Marketing Officer
Delivering attractive growth across the regions Lisa Paley, President, North America
Running a responsible business, integral to all we do Teri Lyng, Head of Transformation and Sustainability
Committed to delivering attractive & sustainable growth, maximizing shareholder value Tobias Hestler, Chief Financial Officer
Bringing it all together Brian McNamara, Chief Executive Officer